IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v1y2017i1d10.1007_s41669-016-0004-1.html
   My bibliography  Save this article

Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review

Author

Listed:
  • Ilke Akpinar

    (Antalya Training and Research Hospital)

  • Philip Jacobs

    (University of Alberta
    Institute of Health Economics)

  • Tien Dat Tran

    (Institute of Health Economics
    University of Alberta)

Abstract

Background Economic evaluation helps policy makers and healthcare payers make decisions on drug listing, coverage, and reimbursement. When economic evaluations are conducted before a product launch, the prices of the pharmaceuticals have to be forecast. Objective The aim of this study was to examine the methods of establishing proxy prices and their accuracies compared with actual market prices after the product launch. Methods We searched the literature for evaluations for drugs that were licensed in the US between 2010 and 2015. We reviewed the studies for the forecasting strategies used, and then estimated the difference between actual 2016 post-launch prices and what the proxy prices would be if the forecast was carried out in the US in 2016. Results We identified six such studies, with seven drugs. Four studies used substitute drugs as proxies for the study drug, and three used other methods. The range of the values of actual minus proxy price varied considerably, and no trend was observed. Conclusion Forecasting drug prices is as precarious as forecasting in other areas of the economy. We urge caution in reviewing and accepting a cost-effectiveness ratio that is based on forecast prices.

Suggested Citation

  • Ilke Akpinar & Philip Jacobs & Tien Dat Tran, 2017. "Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review," PharmacoEconomics - Open, Springer, vol. 1(1), pages 65-68, March.
    • Handle: RePEc:spr:pharmo:v:1:y:2017:i:1:d:10.1007_s41669-016-0004-1
    DOI: 10.1007/s41669-016-0004-1
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-016-0004-1
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s41669-016-0004-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ilke Akpinar & Arto Ohinmaa & Lars Thording & Dat T. Tran & Richard N. Fedorak & Lawrence Richer & Philip Jacobs, 2019. "The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta," PharmacoEconomics - Open, Springer, vol. 3(4), pages 591-597, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:1:y:2017:i:1:d:10.1007_s41669-016-0004-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.